ARTV - Artiva Biotherapeutics, Inc.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 4.91

Open

$ 5.68

Bid

$ 4.57 x 25

Ask

$ 4.93 x 30

Day's Range

$ 4.12 - $ 5.70

52 Week Range

$ 1.47 - $ 15.49

Volume

3,141,697

Average Volume

Market Cap

119.93M

Beta (5Y Monthly)

$ 0.64

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-24-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-29-2024	06-30-2024	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Monday's I...
10/20/2025 18:39:30

Why Is Artiva Up Today?
10/17/2025 19:07:44

Shares of Artiva Biotherapeutics, Inc. are rising Friday after the San Diego-based biotech company shared a milestone regulator...

12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

gold-falls-1-slb-posts-better-than-expected-q3-earnings

Gold Falls 1%; SLB Posts Better-Than-Expec...
10/17/2025 16:17:56

dow-gains-over-100-points-american-express-increases-2025-forecast

Dow Gains Over 100 Points; American Expres...
10/17/2025 13:55:00

Wedbush Maintains Outperform on Artiva Bio...
10/17/2025 12:29:35

Wedbush analyst Martin Fan maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Outperform and raises the price target fro...

12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

Market-Moving News for October 17th
10/17/2025 11:27:43

CSX: 3% | CSX shares are trading higher after the company reported better-than-expected Q3 financial results. ARTV: 144% | Arti...

Needham Reiterates Buy on Artiva Biotherap...
10/17/2025 10:34:44

Needham analyst Gil Blum reiterates Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and maintains $18 price target.

why-csx-shares-are-trading-higher-by-over-4-here-are-20-stocks-moving-premarket

Why CSX Shares Are Trading Higher By Over ...
10/17/2025 09:55:54

12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

Artiva Biotherapeutics Receives FDA Fast T...
10/16/2025 20:08:51

SAN DIEGO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) (Artiva), a clinical-stage biotechnolog...

12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

Artiva Biotherapeutics Files For Mixed She...
08/06/2025 21:40:57

-SEC Filing

Artiva Biotherapeutics Q2 EPS $(0.87) Miss...
08/06/2025 20:57:53

12 Health Care Stocks Moving In Wednesday'...
07/23/2025 21:05:58

HC Wainwright & Co. Assumes Artiva Biother...
06/11/2025 11:03:51

HC Wainwright & Co. analyst Emily Bodnar assumes Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy rating and announces Pr...

Needham Maintains Buy on Artiva Biotherape...
05/15/2025 10:07:17

Needham analyst Gil Blum maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy and lowers the price target from $23 to $18.

Artiva Biotherapeutics Announces Longer-Te...
05/13/2025 20:30:37

64% (9/14) complete response rate with AlloNK + rituximab in heavily pretreated patients that were naïve to prior CAR-T cell th...

Artiva Biotherapeutics Q1 EPS $(0.83) Miss...
05/08/2025 12:11:40

Artiva Biotherapeutics (NASDAQ:ARTV) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate...